Sodium valproate, its main effect is to inhibit seizures. Sodium valproate belongs to the antiepileptic drugs, its mechanism of action has not been fully clarified, experiments can be seen to increase the synthesis of γ-aminobutyric acid and reduce the degradation, thus reducing the excitability of neurons, inhibit seizures. This product is mainly used for the treatment of simple or complex apoplectic seizures, myoclonic seizures and grand mal seizures, and sometimes can also be used for complex partial seizures. Adverse reactions such as diarrhea, dyspepsia, nausea, menstrual cycle changes, and hepatic impairment have been seen with sodium valproate. It is contraindicated in persons with a family or personal history of pharmacogenetic jaundice, and in persons with liver disease or significant hepatic impairment. It is cautiously used in people with blood diseases, renal function impairment, and organic encephalopathy. It is recommended to follow the doctor’s instructions to use the drug, pay attention to the adverse drug reactions.